Citadel Advisors »

Belite Bio shares owned by Citadel Advisors

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $801k 11k 74.00
2025-06-30 $430k 7.5k 57.70
2025-03-31 $377k 5.7k 66.22
2024-12-31 $329k 5.2k 63.10
2024-09-30 $303k 6.5k 46.88

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Belite Bio

RA Capital Management
Rtw Investments
Vestal Point Capital
Soleus Capital Management
Eventide Asset Management
Marshall Wace
Perceptive Advisors
Millennium Management
Geode Capital Management
State Street Corporation
Bnp Paribas Arbitrage, Snc
UBS Group
Citadel Advisors
Jpmorgan Chase & Co
Polymer Capital Management

View all funds holding Belite Bio